{"transactions":[{"id":1859033,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112448,"kind":"person","name":"Giesing Dennis H","position":1,"cik":"0001853622","reported_name":"Giesing Dennis H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T16:47:24.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-forty-eighth (1/48th) of the shares subject to such options shall vest monthly over forty-eight months after the grant date."}],"balance_after":50000,"derivative":{"exercise_price":4.84,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-23-070394","document":"tm2318426-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853622/000110465923070394/tm2318426-1_4seq1.xml","form_type":"4"}},{"id":2225685,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112448,"kind":"person","name":"Giesing Dennis H","position":1,"cik":"0001853622","reported_name":"Giesing Dennis H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T18:05:21.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"With respect to the options to purchase 30,000 shares, 25% of the shares subject to such options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to such options shall vest every month thereafter. With respect to the remaining options to purchase 30,000 shares, 50% of the shares subject to such options vest on June 16, 2023, and the remaining 50% of the shares subject to such options vest on June 16, 2024."}],"balance_after":60000,"derivative":{"exercise_price":3.42,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-22-073101","document":"tm2218674-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853622/000110465922073101/tm2218674-7_4seq1.xml","form_type":"4"}},{"id":2689202,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112448,"kind":"person","name":"Giesing Dennis H","position":1,"cik":"0001853622","reported_name":"Giesing Dennis H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T19:16:26.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":16609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the option shall vest every month thereafter."}],"balance_after":16609,"derivative":{"exercise_price":20.92,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":16609},"source":{"system":"sec-edgar","filing":"0001104659-21-075233","document":"tm2118079d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853622/000110465921075233/tm2118079d2_4seq1.xml","form_type":"4"}},{"id":2769535,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112448,"kind":"person","name":"Giesing Dennis H","position":1,"cik":"0001853622","reported_name":"Giesing Dennis H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-29T20:50:57.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on March 23, 2022, and the remaining 75% of shares subject to the option shall vest in equal monthly installments for the 36 months thereafter."}],"balance_after":125000,"derivative":{"exercise_price":31.83,"expiration_date":"2031-03-24","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-21-043486","document":"tm2111257-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853622/000110465921043486/tm2111257-2_4seq1.xml","form_type":"4"}}]}